Virulence diversity among bacteremic Aeromonas isolates: ex vivo, animal, and clinical evidences

PLoS One. 2014 Nov 6;9(11):e111213. doi: 10.1371/journal.pone.0111213. eCollection 2014.

Abstract

Background: The objective of this study was to compare virulence among different Aeromonas species causing bloodstream infections.

Methodology/principal findings: Nine of four species of Aeromonas blood isolates, including A. dhakensis, A. hydrophila, A. veronii and A. caviae were randomly selected for analysis. The species was identified by the DNA sequence matching of rpoD. Clinically, the patients with A. dhakensis bacteremia had a higher sepsis-related mortality rate than those with other species (37.5% vs. 0%, P = 0.028). Virulence of different Aeromonas species were tested in C. elegans, mouse fibroblast C2C12 cell line and BALB/c mice models. C. elegans fed with A. dhakensis and A. caviae had the lowest and highest survival rates compared with other species, respectively (all P values <0.0001). A. dhakensis isolates also exhibited more cytotoxicity in C2C12 cell line (all P values <0.0001). Fourteen-day survival rate of mice intramuscularly inoculated with A. dhakensis was lower than that of other species (all P values <0.0001). Hemolytic activity and several virulence factor genes were rarely detected in the A. caviae isolates.

Conclusions/significance: Clinical data, ex vivo experiments, and animal studies suggest there is virulence variation among clinically important Aeromonas species.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aeromonas / genetics
  • Aeromonas / isolation & purification
  • Aeromonas / pathogenicity*
  • Animals
  • Bacteremia
  • Caenorhabditis elegans
  • Gram-Negative Bacterial Infections / microbiology*
  • Mice
  • Virulence
  • Virulence Factors / genetics*

Substances

  • Virulence Factors

Associated data

  • figshare/10.6084/M9.FIGSHARE.1180129
  • figshare/10.6084/M9.FIGSHARE.1180130
  • figshare/10.6084/M9.FIGSHARE.1180131
  • figshare/10.6084/M9.FIGSHARE.1180136

Grants and funding

The study was supported by the grants from, National Science Council, National Cheng Kung University Hospital, National Health Research Institutes, and Ministry of Health and Welfare (A Landmark Project to Promote Innovation & Competitiveness of Clinical Trials by the Excellent Clinical Trial and Research Center), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.